Histogenics (NASDAQ:HSGX) Trading Down 11.1%
Histogenics Corp (NASDAQ:HSGX)’s stock price traded down 11.1% on Tuesday . The company traded as low as $0.23 and last traded at $0.24, 10,423,882 shares were traded during mid-day trading. An increase of 18% from the average session volume of 8,867,679 shares. The stock had previously closed at $0.27.
Separately, ValuEngine upgraded shares of Histogenics from a “hold” rating to a “buy” rating in a report on Thursday, August 1st.
The firm’s 50-day moving average price is $0.21 and its two-hundred day moving average price is $0.18. The stock has a market cap of $25.44 million, a PE ratio of -0.31 and a beta of 3.10.
Histogenics Company Profile (NASDAQ:HSGX)
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Read More: Momentum Indicators
Receive News & Ratings for Histogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Histogenics and related companies with MarketBeat.com's FREE daily email newsletter.